Document Detail


Call to action: finding solutions for the drug shortage crisis in the United States.
MedLine Citation:
PMID:  23337524     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
In their article in this issue of CPT, Woodcock and Wosinska are the first to clearly outline the quality and manufacturing problems causing drug shortages of generic injectables. These authors have focused on the main issue, namely, that manufacturing problems and the lack of incentives for quality products are the primary reasons for most recent shortages of generic injectable drugs.
Authors:
E R Fox; L S Tyler
Related Documents :
3416744 - Endotracheal tobramycin in gram-negative pneumonitis.
12400924 - Exposure to anti-cancer drugs during preparation and administration. investigations of ...
17817364 - Oral administration of penicillin.
3694434 - Effects of beta- and gamma-cyclodextrins on the pharmacokinetic behavior of prednisolon...
22475524 - Olanzapine and risperidone effects on appetite and ghrelin in chronic schizophrenic pat...
17174424 - Rationality and drug use: an experimental approach.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Clinical pharmacology and therapeutics     Volume:  93     ISSN:  1532-6535     ISO Abbreviation:  Clin. Pharmacol. Ther.     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-01-22     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372741     Medline TA:  Clin Pharmacol Ther     Country:  United States    
Other Details:
Languages:  eng     Pagination:  145-7     Citation Subset:  AIM; IM    
Affiliation:
Drug Information Service, University of Utah, Salt Lake City, Utah, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pharmacy benefit managers and their obligations during serious prescription drug shortages.
Next Document:  Economic and technological drivers of generic sterile injectable drug shortages.